| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of Psychiatry, Anesthesiology and Diagnostic Radiology, Yale University School of Medicine, New Haven, Connecticut
Department of Veterans Affairs Medical Center, West Haven, Connecticut
Division of Nuclear Medicine, Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania
Correspondence: For correspondence or reprints contact: Marc Laruelle, MD, Department of Psychiatry, Yale School of Medicine, West Haven VA Medical Center/116A2, West Haven, CT 06516.
ABSTRACT
This study assesses the feasibility of using SPECT to image intrasynaptic dopamine release in human striatum following dextroamphetamine sultate (d-amphetamine) challenge testing. Methods: A bolus plus constant infusion administration schedule of the D2 receptor radiotracer [123I]iodobenzamide ([123I]IBZM) was used to obtain a stable baseline for reliable quantitation of the d-amphetamine effect. Eight healthy subjects first under went a controlled experiment to demonstrate that stable levels of striatal and occipital activities could be maintained from 150 to 420 min during programmed infusion of the tracer. Next, seven subjects underwent the experiment with d-amphetamine. The experimental conditions were identical except that 0.3 mg/kg amphetamine was injected intravenously at 240 min. The behavioral effects of d-amphetamine were measured by self-rating on the following analog scales: euphoria, alertness, restlessness and anxiety. Results: The d-amphetamine injection induced a 15%± 4% (mean ± s.d.) decrease in D2 receptor availabllfty, measured as the specific-to-nonspecific equilibrium partition coefficient (V3"). Thed-amphetamine injection induced markedi ncrease in euphoria, alertness and restlessness scores. The intensity of these behavioral responses correlated with the decrease in D2 availability measured with SPECT. In contrast, the anxioty response was milder and not correlated with the decreasein D2 availability. Conclusion: These studies demonstrate the feasibility of using [123I]IBZM programmed infusion and SPECT imaging to measure endogenous dopamine release after d-amphetamine challenge and to study brain neurochemical correlates of emotions.
Key Words: single-photon emission computed tomography • dopamine D2 receptors • iodine-123-IBZM • equilibrium analysis
This article has been cited by other articles:
|
|
 |
|
  K. L. Lanctot, N. Herrmann, S. E. Black, M. Ryan, L. S. Rothenburg, B. A. Liu, and U. E. Busto Apathy Associated with Alzheimer Disease: Use of Dextroamphetamine Challenge Am J Geriatr Psychiatry, July 1, 2008; 16(7): 551 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. den Boer, A.A.T. S. Reinders, and G. Glas Special Section: On Looking Inward: Revisiting the Role of Introspection in Neuroscientific and Psychiatric Research Theory Psychology, June 1, 2008; 18(3): 380 - 403. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Martinez, R. Narendran, R. W. Foltin, M. Slifstein, D.-R. Hwang, A. Broft, Y. Huang, T. B. Cooper, M. W. Fischman, H. D. Kleber, et al. Amphetamine-Induced Dopamine Release: Markedly Blunted in Cocaine Dependence and Predictive of the Choice to Self-Administer Cocaine Am J Psychiatry, April 1, 2007; 164(4): 622 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Fitzmaurice, J. Tong, M. Yazdanpanah, P. P. Liu, K. S. Kalasinsky, and S. J. Kish Levels of 4-Hydroxynonenal and Malondialdehyde Are Increased in Brain of Human Chronic Users of Methamphetamine J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 703 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Scott, M. M. Heitzeg, R. A. Koeppe, C. S. Stohler, and J.-K. Zubieta Variations in the human pain stress experience mediated by ventral and dorsal Basal Ganglia dopamine activity. J. Neurosci., October 18, 2006; 26(42): 10789 - 10795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. K. Tremblay, C. A. Naranjo, S. J. Graham, N. Herrmann, H. S. Mayberg, S. Hevenor, and U. E. Busto Functional Neuroanatomical Substrates of Altered Reward Processing in Major Depressive Disorder Revealed by a Dopaminergic Probe Arch Gen Psychiatry, November 1, 2005; 62(11): 1228 - 1236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. D. Volkow, G.-J. Wang, J. S. Fowler, F. Telang, L. Maynard, J. Logan, S. J. Gatley, N. Pappas, C. Wong, P. Vaska, et al. Evidence That Methylphenidate Enhances the Saliency of a Mathematical Task by Increasing Dopamine in the Human Brain Am J Psychiatry, July 1, 2004; 161(7): 1173 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. McGowan, A. D. Lawrence, T. Sales, D. Quested, and P. Grasby Presynaptic Dopaminergic Dysfunction in Schizophrenia: A Positron Emission Tomographic [18F]Fluorodopa Study Arch Gen Psychiatry, February 1, 2004; 61(2): 134 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Moszczynska, P. Fitzmaurice, L. Ang, K. S. Kalasinsky, G. A. Schmunk, F. J. Peretti, S. S. Aiken, D. J. Wickham, and S. J. Kish Why is parkinsonism not a feature of human methamphetamine users? Brain, February 1, 2004; 127(2): 363 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Grunder, A. Carlsson, and D. F. Wong Mechanism of New Antipsychotic Medications: Occupancy Is Not Just Antagonism Arch Gen Psychiatry, October 1, 2003; 60(10): 974 - 977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tong, B. M. Ross, G. A. Schmunk, F. J. Peretti, K. S. Kalasinsky, Y. Furukawa, L. C. Ang, S. S. Aiken, D. J. Wickham, and S. J. Kish Decreased Striatal Dopamine D1 Receptor- Stimulated Adenylyl Cyclase Activity in Human Methamphetamine Users Am J Psychiatry, May 1, 2003; 160(5): 896 - 903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Yamane, Y. Tohyama, and M. Diksic CONTINUOUS ETHANOL ADMINISTRATION INFLUENCES RAT BRAIN 5-HYDROXYTRYPTAMINE SYNTHESIS NON-UNIFORMLY: {alpha}-[14C]METHYL-L-TRYPTOPHAN AUTORADIOGRAPHIC MEASUREMENTS Alcohol Alcohol., March 1, 2003; 38(2): 115 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A R Lingford-Hughes, S J C Davies, S McIver, T M Williams, M R C Daglish, and D J Nutt Addiction: Imaging in clinical neuroscience Br. Med. Bull., March 1, 2003; 65(1): 209 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Sun, N. Ginovart, F. Ko, P. Seeman, and S. Kapur In Vivo Evidence for Dopamine-Mediated Internalization of D2-Receptors after Amphetamine: Differential Findings with [3H]Raclopride versus [3H]Spiperone Mol. Pharmacol., February 1, 2003; 63(2): 456 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. N. Yatham, P. F. Liddle, R. W. Lam, I-S. Shiah, C. Lane, A. J. Stoessl, V. Sossi, and T. J. Ruth PET Study of the Effects of Valproate on Dopamine D2 Receptors in Neuroleptic- and Mood-Stabilizer-Naive Patients With Nonpsychotic Mania Am J Psychiatry, October 1, 2002; 159(10): 1718 - 1723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. K. Tremblay, C. A. Naranjo, L. Cardenas, N. Herrmann, and U. E. Busto Probing Brain Reward System Function in Major Depressive Disorder: Altered Response to Dextroamphetamine Arch Gen Psychiatry, May 1, 2002; 59(5): 409 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Abi-Dargham, J. Rodenhiser, D. Printz, Y. Zea-Ponce, R. Gil, L. S. Kegeles, R. Weiss, T. B. Cooper, J. J. Mann, R. L. Van Heertum, et al. From the Cover: Increased baseline occupancy of D2 receptors by dopamine in schizophrenia PNAS, July 5, 2000; 97(14): 8104 - 8109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. D. Volkow, G.-J. Wang, J. S. Fowler, J. Logan, S. J. Gatley, C. Wong, R. Hitzemann, and N. R. Pappas Reinforcing Effects of Psychostimulants in Humans Are Associated with Increases in Brain Dopamine and Occupancy of D2 Receptors J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 409 - 415. [Abstract] [Full Text]
|
|
|
|
|
|
A. Abi-Dargham, R. Gil, J. Krystal, R. M. Baldwin, J. P. Seibyl, M. Bowers, C. H. van Dyck, D. S. Charney, R. B. Innis, and M. Laruelle Increased Striatal Dopamine Transmission in Schizophrenia: Confirmation in a Second Cohort Am J Psychiatry, June 1, 1998; 155(6): 761 - 767. [Abstract] [Full Text]
|
|
|
|
|
|
A. Breier, T.-P. Su, R. Saunders, R. E. Carson, B. S. Kolachana, A. de Bartolomeis, D. R. Weinberger, N. Weisenfeld, A. K. Malhotra, W. C. Eckelman, et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method PNAS, March 18, 1997; 94(6): 2569 - 2574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. D. Volkow, G.-J. Wang, J. S. Fowler, J. Logan, M. Gerasimov, L. Maynard, Y.-S. Ding, S. J. Gatley, A. Gifford, and D. Franceschi Therapeutic Doses of Oral Methylphenidate Significantly Increase Extracellular Dopamine in the Human Brain J. Neurosci., January 15, 2001; 21(2): RC121 - RC121. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
